These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24287772)
1. NIH denies march-in rights on Norvir patent. Harrison C Nat Rev Drug Discov; 2013 Dec; 12(12):898. PubMed ID: 24287772 [No Abstract] [Full Text] [Related]
2. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents. Malakoff D Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775 [No Abstract] [Full Text] [Related]
3. Patents. NIH declines to march in on pricing AIDS drug. Malakoff D Science; 2004 Aug; 305(5686):926. PubMed ID: 15310867 [No Abstract] [Full Text] [Related]
4. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir. Huff B GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438 [No Abstract] [Full Text] [Related]
5. Secondary patenting of branded pharmaceuticals: a case study of how patents on two HIV drugs could be extended for decades. Amin T; Kesselheim AS Health Aff (Millwood); 2012 Oct; 31(10):2286-94. PubMed ID: 23048110 [TBL] [Abstract][Full Text] [Related]
6. NIH files counter-patent in breast cancer gene dispute. Nature; 1994 Nov; 372(6502):118. PubMed ID: 7969430 [No Abstract] [Full Text] [Related]
7. Petition fails to reverse massive price rise for AIDS drug. Check E Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778 [No Abstract] [Full Text] [Related]
8. March-in rights under the Bayh-Dole Act: the NIH's paper tiger? O'Brien W Seton Hall Law Rev; 2013 Nov; 43(4):1403-32. PubMed ID: 24308083 [No Abstract] [Full Text] [Related]
9. What the Moderna-NIH COVID vaccine patent fight means for research. Ledford H Nature; 2021 Dec; 600(7888):200-201. PubMed ID: 34853416 [No Abstract] [Full Text] [Related]
10. AIDS drug price hike prompts calls for intervention. Check E Nature; 2004 May; 429(6987):6. PubMed ID: 15129244 [No Abstract] [Full Text] [Related]
11. The demise of Bayh-Dole protections against the Pharmaceutical Industry's abuses of government-funded inventions. Schofield AR J Law Med Ethics; 2004; 32(4):777-83. PubMed ID: 15807367 [No Abstract] [Full Text] [Related]
12. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
13. France wins larger share of patent royalties after AIDS test dispute. Macilwain C Nature; 1994 Jul; 370(6485):85. PubMed ID: 8022487 [No Abstract] [Full Text] [Related]
14. Patent medicine. Baker D J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309 [No Abstract] [Full Text] [Related]
15. AmFAR extols FDA on rapid approval of two protease inhibitors. AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645 [No Abstract] [Full Text] [Related]
16. NIH gets a share of BRCA1 patent. Marshall E Science; 1995 Feb; 267(5201):1086. PubMed ID: 7855586 [No Abstract] [Full Text] [Related]
19. Gene wars escalate as US official battles NIH over pursuit of patent. Anderson C Nature; 1992 Oct; 359(6395):467. PubMed ID: 1406958 [No Abstract] [Full Text] [Related]
20. NIH sues BMS over missing drug royalties. Ready T Nat Med; 2000 Dec; 6(12):1302. PubMed ID: 11100093 [No Abstract] [Full Text] [Related] [Next] [New Search]